Additional grant funding for ‘AI-driven’ infection detection technology
Developing a portfolio of diagnostic tests that address two growing global healthcare challenges: early infection diagnosis and antimicrobial resistance, Presymptom Health will also use the funding to make its rapid tests compatible with a variety of widely available PCR machines, ‘streamlining diagnostics is secondary care’. The company says its InfectiClear technology can detect infection